{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:42Z","timestamp":1789142502874,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C18281\/A19169"],"award-info":[{"award-number":["C18281\/A19169"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Research and Innovation Future Leaders Fellowship","award":["MR\/T043202\/1"],"award-info":[{"award-number":["MR\/T043202\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer (BC) has the highest cancer incidence and mortality in women worldwide. Observational epidemiological studies suggest a positive association between testosterone, estradiol, dehydroepiandrosterone sulphate (DHEAS) and other sex steroid hormones with postmenopausal BC. We used a two-sample Mendelian randomization analysis to investigate this association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Genetic instruments for nine sex steroid hormones and sex hormone-binding globulin (SHBG) were obtained from genome-wide association studies (GWAS) of UK Biobank (total testosterone (TT)\n                      <jats:italic>N<\/jats:italic>\n                      : 230,454, bioavailable testosterone (BT)\n                      <jats:italic>N<\/jats:italic>\n                      : 188,507 and SHBG\n                      <jats:italic>N<\/jats:italic>\n                      : 189,473), The United Kingdom Household Longitudinal Study (DHEAS\n                      <jats:italic>N<\/jats:italic>\n                      : 9722), the LIFE-Adult and LIFE-Heart cohorts (estradiol\n                      <jats:italic>N<\/jats:italic>\n                      : 2607, androstenedione\n                      <jats:italic>N<\/jats:italic>\n                      : 711, aldosterone\n                      <jats:italic>N<\/jats:italic>\n                      : 685, progesterone\n                      <jats:italic>N<\/jats:italic>\n                      : 1259 and 17-hydroxyprogesterone\n                      <jats:italic>N<\/jats:italic>\n                      : 711) and the CORtisol NETwork (CORNET) consortium (cortisol\n                      <jats:italic>N<\/jats:italic>\n                      : 25,314). Outcome GWAS summary statistics were obtained from the Breast Cancer Association Consortium (BCAC) for overall BC risk (\n                      <jats:italic>N<\/jats:italic>\n                      : 122,977 cases and 105,974 controls) and subtype-specific analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that a standard deviation (SD) increase in TT, BT and estradiol increased the risk of overall BC (OR 1.14, 95% CI 1.09\u20131.21, OR 1.19, 95% CI 1.07\u20131.33 and OR 1.03, 95% CI 1.01\u20131.06, respectively) and ER\u2009+\u2009BC (OR 1.19, 95% CI 1.12\u20131.27, OR 1.25, 95% CI 1.11\u20131.40 and OR 1.06, 95% CI 1.03\u20131.09, respectively). An SD increase in DHEAS also increased ER\u2009+\u2009BC risk (OR 1.09, 95% CI 1.03\u20131.16). Subtype-specific analyses showed similar associations with ER+\u2009expressing subtypes: luminal A-like BC, luminal B-like BC and luminal B\/HER2-negative-like BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TT, BT, DHEAS and estradiol increase the risk of ER+\u2009type BCs similar to observational studies. Understanding the role of sex steroid hormones in BC risk, particularly subtype-specific risks, highlights the potential importance of attempts to modify and\/or monitor hormone levels in order to prevent BC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-022-01553-9","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T13:02:52Z","timestamp":1665234172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-1864","authenticated-orcid":false,"given":"Aayah","family":"Nounu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha P.","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline L.","family":"Relton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"key":"1553_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:1\u201341.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"1553_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","volume":"13","author":"N Hamajima","year":"2012","unstructured":"Hamajima N, Hirose K, Tajima K, Rohan T, Friedenreich CM, Calle EE, et al. Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141\u201351.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1553_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/1055-9965.EPI-04-0465","volume":"14","author":"M Chavez-MacGregor","year":"2005","unstructured":"Chavez-MacGregor M, Elias SG, Charlotte Onland-Moret N, Van Der Schouw YT, Van GCH, Monninkhof E, et al. Postmenopausal breast cancer risk and cumulative number of menstrual cycles. Cancer Epidemiol Biomarkers Prev. 2005;14(4):799\u2013804.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1553_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fonc.2016.00267","volume":"6","author":"V Atashgaran","year":"2016","unstructured":"Atashgaran V, Wrin J, Barry SC, Dasari P, Ingman WV. Dissecting the biology of menstrual cycle-associated breast cancer risk. Front Oncol. 2016;6:267.","journal-title":"Front Oncol"},{"issue":"11","key":"1553_CR5","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","volume":"22","author":"JM Gierisch","year":"2013","unstructured":"Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013;22(11):1931\u201343.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10204","key":"1553_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2019","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159\u201368.","journal-title":"Lancet"},{"issue":"8","key":"1553_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"The Endogenous Hormones and Breast Cancer Collaborative Group","year":"2002","unstructured":"The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94(8):606\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1553_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/GME.0000000000000903","volume":"24","author":"JL Shifren","year":"2017","unstructured":"Shifren JL, Davis SR. Androgens in postmenopausal women: a review. Menopause. 2017;24(8):970\u20139.","journal-title":"Menopause"},{"issue":"6","key":"1553_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jaad.2018.08.062","volume":"80","author":"A Bienenfeld","year":"2019","unstructured":"Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol. 2019;80(6):1497\u2013506.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1553_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1677\/erc.1.01038","volume":"12","author":"R Kaaks","year":"2005","unstructured":"Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PHM, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer. 2005;12(4):1071\u201382.","journal-title":"Endocr Relat Cancer"},{"key":"1553_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fendo.2018.00492","volume":"9","author":"P Giovannelli","year":"2018","unstructured":"Giovannelli P, Di DM, Galasso G, Di ZE, Bilancio A, Migliaccio A. The androgen receptor in breast cancer. Front Endocrinol. 2018;9:492.","journal-title":"Front Endocrinol"},{"issue":"10","key":"1553_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","volume":"14","author":"Endogenous Hormones and Breast Cancer Collaborative Group","year":"2013","unstructured":"Endogenous Hormones and Breast Cancer Collaborative Group. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013;14(10):1009\u201319.","journal-title":"Lancet Oncol"},{"key":"1553_CR13","doi-asserted-by":"crossref","unstructured":"Tin Tin S, Reeves GK, Key TJ. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women\u202f: findings from the UK Biobank. Br J Cancer. 2021;Online ahead of print.","DOI":"10.1136\/jech-2021-SSMabstracts.47"},{"issue":"1","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cll.2004.01.004","volume":"24","author":"JP Holst","year":"2004","unstructured":"Holst JP, Soldin OP, Guo T, Soldin SJ. Steroid hormones: relevance and measurement in the clinical laboratory. Clin Lab Med. 2004;24(1):105\u201318.","journal-title":"Clin Lab Med"},{"issue":"200","key":"1553_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.canlet.2014.04.018","volume":"356","author":"H Samavat","year":"2015","unstructured":"Samavat H, Kurzer MS. Estrogen metabolism and breast cancer. Cancer Lett. 2015;356(200):231\u201343.","journal-title":"Cancer Lett"},{"issue":"6","key":"1553_CR16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/er.2003-0030","volume":"25","author":"AH Payne","year":"2004","unstructured":"Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25(6):947\u201370.","journal-title":"Endocr Rev"},{"key":"1553_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2019.108507","volume":"153","author":"P Sahu","year":"2020","unstructured":"Sahu P, Gidwani B, Dhongade HJ. Pharmacological activities of dehydroepiandrosterone: a review. Steroids. 2020;153: 108507.","journal-title":"Steroids"},{"issue":"3","key":"1553_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1210\/er.2003-0016","volume":"25","author":"W Somboonporn","year":"2004","unstructured":"Somboonporn W, Davis SR. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev. 2004;25(3):374\u201388.","journal-title":"Endocr Rev"},{"issue":"4","key":"1553_CR19","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0015-0282(02)02984-9","volume":"77","author":"ER Simpson","year":"2002","unstructured":"Simpson ER. Aromatization of androgens in women: current concepts and findings. Fertil Steril. 2002;77(4):S6-10.","journal-title":"Fertil Steril"},{"issue":"1","key":"1553_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/30.1.1","volume":"30","author":"GD Smith","year":"2001","unstructured":"Smith GD, Ebrahim S. Epidemiology: Is it time to call it a day\u202f? Int J Epidemiol. 2001;30(1):1\u201311.","journal-title":"Int J Epidemiol"},{"issue":"R1","key":"1553_CR21","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89-98.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"1553_CR22","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/1471-0528.15199","volume":"125","author":"E Hariton","year":"2018","unstructured":"Hariton E, Locascio JJ. Randomised controlled trials\u2014the gold standard for effectiveness research. BJOG. 2018;125(13):1716.","journal-title":"BJOG"},{"issue":"1","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"G Davey Smith","year":"2003","unstructured":"Davey Smith G, Ebrahim S. \u201cMendelian randomization\u201d: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"1553_CR24","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363.","journal-title":"Stat Med"},{"issue":"7499","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/bmj.330.7499.1076","volume":"330","author":"G Davey Smith","year":"2005","unstructured":"Davey Smith G, Ebrahim S. What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures? Br Med J. 2005;330(7499):1076\u20139.","journal-title":"Br Med J"},{"issue":"5","key":"1553_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/aje\/kwj062","volume":"163","author":"D Nitsch","year":"2006","unstructured":"Nitsch D, Molokhia M, Smeeth L, DeStavola BL, Whittaker JC, Leon DA. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol. 2006;163(5):397\u2013403.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252\u20138.","journal-title":"Nat Med"},{"issue":"3","key":"1553_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/ije\/dyz107","volume":"48","author":"NL Dimou","year":"2019","unstructured":"Dimou NL, Papadimitriou N, Gill D, Christakoudi S, Murphy N, Gunter MJ, et al. Mendelian Randomization Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study. Int J Epidemiol. 2019;48(3):807\u201316.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"1553_CR29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/ije\/dyw127","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor DA. Commentary: two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol. 2016;45(3):908\u201315. https:\/\/doi.org\/10.1093\/ije\/dyw127.","journal-title":"Int J Epidemiol"},{"issue":"7726","key":"1553_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"key":"1553_CR31","unstructured":"Fry D, Almond R, Moffat S, Gordon M, Singh P. UK Biobank Biomarker Project Companion Document to Accompany Serum Biomarker Data. 2019 [cited 2021 Jul 7]; Available from: https:\/\/biobank.ndph.ox.ac.uk\/ukb\/ukb\/docs\/serum_biochemistry.pdf"},{"issue":"5","key":"1553_CR32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/ijc.31394","volume":"143","author":"W Guo","year":"2018","unstructured":"Guo W, Key TJ, Reeves GK. Adiposity and breast cancer risk in postmenopausal women: results from the UK Biobank prospective cohort. Int J Cancer. 2018;143(5):1037\u201346.","journal-title":"Int J Cancer"},{"issue":"3","key":"1553_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009161","volume":"6","author":"J Hewitt","year":"2016","unstructured":"Hewitt J, Walters M, Padmanabhan S, Dawson J. Cohort profile of the UK Biobank: diagnosis and characteristics of cerebrovascular disease. BMJ Open. 2016;6(3): e009161.","journal-title":"BMJ Open"},{"key":"1553_CR34","unstructured":"UK Biobank Biomarker assay quality procedures: approaches used to minimise systematic and random errors (and the wider epidemiological implications) [Internet]. 2019 [cited 2021 Aug 10]. Available from: https:\/\/biobank.ctsu.ox.ac.uk\/crystal\/ukb\/docs\/biomarker_issues.pdf"},{"key":"1553_CR35","unstructured":"Estradiol III [Internet]. [cited 2021 Jul 7]. Available from: https:\/\/www.rochecanada.com\/content\/dam\/rochexx\/roche-ca\/products\/docs\/package_inserts\/ESTRADIOLIII_06656021190_CAN_V4_EN-final.pdf"},{"key":"1553_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.chroma.2016.07.087","volume":"1464","author":"A Gaudl","year":"2016","unstructured":"Gaudl A, Kratzsch J, Bae YJ, Kiess W, Thiery J, Ceglarek U. Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma, urine, saliva and hair. J Chromatogr A. 2016;1464:64\u201371.","journal-title":"J Chromatogr A"},{"issue":"11","key":"1553_CR37","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1210\/jc.2019-00757","volume":"104","author":"J Pott","year":"2019","unstructured":"Pott J, Bae YJ, Horn K, Teren A, K\u00fchnapfel A, Kirsten H, et al. Genetic association study of eight steroid hormones and implications for sexual dimorphism of coronary artery disease. J Clin Endocrinol Metab. 2019;104(11):5008\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1553_CR38","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1038\/s41598-017-10812-1","volume":"7","author":"BP Prins","year":"2017","unstructured":"Prins BP, Kuchenbaecker KB, Bao Y, Smart M, Zabaneh D, Fatemifar G, et al. Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations. Sci Rep. 2017;7(1):11008.","journal-title":"Sci Rep"},{"issue":"6","key":"1553_CR39","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s10038-020-00895-6","volume":"66","author":"AA Crawford","year":"2021","unstructured":"Crawford AA, Bankier S, Altmaier E, Barnes CLK, Clark DW, Ermel R, et al. Variation in the SERPINA6\/SERPINA1 locus alters morning plasma cortisol, hepatic corticosteroid binding globulin expression, gene expression in peripheral tissues, and risk of cardiovascular disease. J Hum Genet. 2021;66(6):625\u201336.","journal-title":"J Hum Genet"},{"key":"1553_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and \/ or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"1553_CR41","unstructured":"Higgins JPT, Li T, Deeks JJ. Chapter 6: Choosing effect measures and computing estimates of effect. In: Deeks JJ, editor. Cochrane Handbook for Systematic Reviews of Interventions version 62 [Internet]. 2021 [cited 2021 Aug 10]. Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-06#section-6-5"},{"issue":"4","key":"1553_CR42","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng J, Baird D, Borges M-C, Bowden J, Hemani G, Haycock P, et al. Recent developments in mendelian randomization studies. Curr Epidemiol Rep. 2017;4(4):330\u201345. https:\/\/doi.org\/10.1007\/s40471-017-0128-6.","journal-title":"Curr Epidemiol Rep."},{"issue":"3","key":"1553_CR43","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"key":"1553_CR44","unstructured":"mRnd: Power calculations for Mendelian Randomization [Internet]. [cited 2019 Feb 14]. Available from: http:\/\/cnsgenomics.com\/shiny\/mRnd\/"},{"issue":"7678","key":"1553_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou K, Lindstr\u00f6m S, Dennis J, Beesley J, Hui S, Kar S, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551(7678):92\u20134.","journal-title":"Nature"},{"issue":"6","key":"1553_CR46","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","volume":"52","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020;52(6):572\u201381.","journal-title":"Nat Genet"},{"key":"1553_CR47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7: e34408.","journal-title":"Elife"},{"issue":"R2","key":"1553_CR48","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Smith GD. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195-208.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1553_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"11","key":"1553_CR50","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Grecom F, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36(11):1783\u2013802.","journal-title":"Stat Med"},{"issue":"4","key":"1553_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob EAW, Burgess S. A comparison of robust mendelian randomization methods using summary data. Genet Epidemiol. 2020;44(4):313\u201329.","journal-title":"Genet Epidemiol"},{"issue":"6","key":"1553_CR52","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1553_CR53","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"1553_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"1553_CR55","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh P-R, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47(11):1236\u201341.","journal-title":"Nat Genet"},{"key":"1553_CR56","unstructured":"rs2414098 (SNP) - Genes and regulation - Homo_sapiens - GRCh37 Archive browser 103 [Internet]. [cited 2021 Apr 7]. Available from: http:\/\/grch37.ensembl.org\/Homo_sapiens\/Variation\/Mappings?db=core;r=15:51537306-51538306;v=rs2414098;vdb=variation;vf=319531266"},{"issue":"3","key":"1553_CR57","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740\u201352.","journal-title":"Int J Epidemiol"},{"issue":"10","key":"1553_CR58","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1210\/en.2003-0567","volume":"144","author":"J Frasor","year":"2003","unstructured":"Frasor J, Danes JM, Komm B, Chang KCN, Lyttle CR, Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells\u202f: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 2003;144(10):4562\u201374.","journal-title":"Endocrinology"},{"issue":"7","key":"1553_CR59","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/modpathol.2011.54","volume":"24","author":"LC Collins","year":"2011","unstructured":"Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses\u2019 Health Study. Mod Pathol. 2011;24(7):924\u201331.","journal-title":"Mod Pathol"},{"issue":"2","key":"1553_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/modpathol.2009.159","volume":"23","author":"LA Niemeier","year":"2010","unstructured":"Niemeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol. 2010;23(2):205\u201312.","journal-title":"Mod Pathol"},{"issue":"1","key":"1553_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13058-019-1118-z","volume":"21","author":"KH Kensler","year":"2019","unstructured":"Kensler KH, Regan MM, Heng YJ, Baker GM, Pyle ME, Schnitt SJ, et al. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1\u201398. Breast Cancer Res. 2019;21(1):30.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"1553_CR62","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1158\/1541-7786.MCR-16-0167","volume":"14","author":"NCD Amato","year":"2016","unstructured":"Amato NCD, Gordon MA, Babbs B, Spoelstra NS, Butterfield KTC, Torkko KC, et al. Cooperative dynamics of AR and ER activity in breast cancer. Mol Cancer Res. 2016;14(11):1054\u201367.","journal-title":"Mol Cancer Res"},{"issue":"5","key":"1553_CR63","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/bcr3040","volume":"13","author":"SS Tworoger","year":"2011","unstructured":"Tworoger SS, Rosner BA, Willett WC, Hankinson SE. The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res. 2011;13(5):R99.","journal-title":"Breast Cancer Res"},{"key":"1553_CR64","first-page":"5","volume":"32","author":"GL Gretchen","year":"2010","unstructured":"Gretchen GL, Burke A, Anderson WF. Epidemiology of triple negative breast cancers. Breast Dis. 2010;32:5\u201324.","journal-title":"Breast Dis"},{"key":"1553_CR65","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1055-9965.EPI-17-1177","volume":"27","author":"J Yarmolinsky","year":"2018","unstructured":"Yarmolinsky J, Wade KH, Richmond RC, Langdon RJ, Bull CJ, Tilling KM, et al. Causal inference in cancer epidemiology: What is the role of Mendelian randomization? Cancer Epidemiol Biomarkers Prev. 2018;27:995\u20131011.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"1553_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ije\/dyh132","volume":"33","author":"G Davey Smith","year":"2004","unstructured":"Davey Smith G, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30\u201342.","journal-title":"Int J Epidemiol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01553-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-022-01553-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01553-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T14:09:38Z","timestamp":1665238178000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-022-01553-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1186\/s13058-022-01553-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742356001.793598629","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.14.21264952","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC), which covers the UK. Both LIFE-Adult and LIFE-Heart meet the ethical standards of the Declaration of Helsinki. The Ethics Committee of the Medical Faculty of the University Leipzig (Leipzig, Germany) has approved both studies (LIFE-Adult, Registration No. 263-2009-14122009; LIFE-Heart, Registration No. 276e2005). All participants of CORNET provided written informed consent, and studies were approved by local Research Ethics Committees and\/or Institutional Review Boards. All participating studies from BCAC were approved by their appropriate ethics or institutional review board, and all participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}